HealthcareServices

Global Single-Molecule Real-Time Sequencing (SMRT) Market Forecast 2026–2035: Long-Term Growth Insights

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the single-molecule real-time sequencing (smrt) market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Single-Molecule Real-Time Sequencing (SMRT) Market from 2026 to 2030?

The single-molecule real-time sequencing (smrt) market has experienced robust growth in recent years. It is projected to expand from $3.36 billion in 2025 to $3.63 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.1%. The growth observed in the historic period can be attributed to several factors, including the expansion of genomic research initiatives, the increasing adoption of next-generation sequencing platforms, a growing demand for whole genome sequencing, rising investments in life sciences research, and advancements in sequencing chemistry.

The single-molecule real-time sequencing (smrt) market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $4.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. Key drivers for this growth during the forecast period include the expanding application of precision medicine, increasing demand for population-scale genomic studies, broader use of clinical genomics, greater integration of AI-powered bioinformatics, and augmented funding for sophisticated sequencing technologies. Prominent trends expected over the forecast period encompass a wider adoption of long-read sequencing, increased utilization of smrt sequencing for identifying structural variants, growing need for highly accurate epigenetic analysis, broadening of real-time sequencing workflows, and a heightened emphasis on resolving complex genomes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19696&type=smp

What Drivers Are Affecting Demand In The Single-Molecule Real-Time Sequencing (SMRT) Market?

The increasing demand for precision medicine is projected to fuel the expansion of the single-molecule real-time sequencing (SMRT) market in the future. Precision medicine, also known as personalized medicine, is a medical strategy that customizes treatment and healthcare plans for individual patients, taking into account their genetic, environmental, and lifestyle factors. This growing need for personalized medicine stems from breakthroughs in genomic technologies, which facilitate more precise and tailored treatments, alongside a greater focus on individualized patient care to achieve improved outcomes. Single-molecule real-time sequencing (SMRT) significantly bolsters precision medicine by delivering detailed and accurate genomic and epigenetic data, thereby leading to enhanced diagnosis, customized treatments, and better patient results. As an illustration, in May 2025, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines in 2023, making up approximately 38% of all newly approved therapeutic molecular entities, as reported by the U.S.-based professional organization, the Personalized Medicine Coalition (PMC). Consequently, the escalating demand for precision medicine is a key factor driving growth in the single-molecule real-time sequencing (SMRT) market. The increasing occurrence of genetic disorders is anticipated to stimulate the growth of the single-molecule real-time sequencing (SMRT) market moving forward. Genetic disorders are health conditions resulting from anomalies in an individual’s DNA, which can either be inherited or develop from mutations, impacting physical development, metabolism, or overall health. The rising prevalence of genetic disorders is mainly attributed to heightened awareness, advancements in diagnostic technologies, and factors such as environmental influences and parental age. Single-molecule real-time sequencing (SMRT) plays a crucial role in genetic disorders by providing accurate, long-read DNA sequences, which enables the identification of complex mutations and structural variations that might be overlooked by conventional methods. For example, in March 2024, according to the Gene People, a UK-based registered charity for people with genetic disorders, there are more than 6,000 genetic conditions, with new ones being discovered daily. In the UK, 1 in 25 children are affected, leading to 30,000 new diagnoses annually and over 2.4 million individuals living with genetic conditions. Hence, the escalating incidence of genetic disorders is a significant impetus for growth in the single-molecule real-time sequencing (SMRT) market.

Which Segments Are Gaining Traction In The Single-Molecule Real-Time Sequencing (SMRT) Market?

The single-molecule real-time sequencing (smrt) market covered in this report is segmented –

1) By Product: Consumable, Instrument, Services

2) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications

3) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End-Users

Subsegments:

1) By Consumable: Reagents, Sample Preparation Kits, Flow Cells

2) By Instrument: SMRT Sequencers, Accessories, Software

3) By Services: Data Analysis Services, Sequencing Services, Technical Support Services

Who Are The Major Companies Operating In The Single-Molecule Real-Time Sequencing (SMRT) Market?

Major companies operating in the single-molecule real-time sequencing (smrt) market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen N.V., BGI Group, 10x Genomics Inc., Ginkgo Bioworks Inc., Oxford Nanopore Technologies Limited, Genewiz Inc., Pacific Biosciences of California Inc., Macrogen Inc., Element Biosciences Inc., Asuragen Inc., BioNano Genomics Inc., Zymo Research Corporation, Dovetail Genomics LLC, SeqWell Inc., Paragon Genomics Inc., Nabsys Inc., Eurofins Scientific SE, Novogene Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/single-molecule-real-time-sequencing-smrt-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Single-Molecule Real-Time Sequencing (SMRT) Market?

North America was the largest region in the single-molecule real-time sequencing (SMRT) market in 2025. The regions covered in the single-molecule real-time sequencing (smrt) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Single-Molecule Real-Time Sequencing (SMRT) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19696&type=smp

Browse Through More Reports Similar to the Global Single-Molecule Real-Time Sequencing (SMRT) Market 2026, By The Business Research Company

Typhoid Vi Polysaccharide Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Molecular Biology Enzymes And Kits And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/molecular-biology-enzymes-and-kits-and-reagents-global-market-report

Neuroscience Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuroscience-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795